Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Saturday, 21 May 2022, 08:20 HKT/SGT
Share:
    

Source: Straumann Group
Straumann Malaysia, part of The Straumann Group, a Leading Implantology Company, Intends to Provide 3,000 Dental Implant Packages to the Ministry of Health Malaysia as part of MoU

PUTRAJAYA, Malaysia, May 21, 2022 - (ACN Newswire) - Straumann Group Sdn. Bhd, the Malaysian subsidiary of Straumann Group, global leader in implantology and aesthetic-dentistry, (Straumann Malaysia) intends to provide 3,000 dental implant packages worth in excess of RM10 million, which will benefit the lower-income group (B40) and underprivileged Malaysians. This intention was communicated within the Memorandum of Understanding (MoU) announced by the Ministry of Health Malaysia (MOH).

Mr. Guillaume Daniellot, CEO of Straumann Group; Yang Berhormat Tuan Khairy Jamaluddin, Minister of Health Malaysia [L-R]

The discussion of the MoU was led by Malaysia's Minister of Health, Yang Berhormat Tuan Khairy Jamaluddin and the Straumann Group's Chief Executive Officer, Guillaume Daniellot.

Straumann Group's Chief Executive Officer, Guillaume Daniellot said, "This is a significant milestone for the Straumann Group, and we appreciate MOH's willingness to collaborate with us. Oral, especially dental health is critical to everyone's wellbeing, and we believe that everyone has the right to quality medical treatments, especially holistic and ethical dental treatments. This Programme is part of the broader community oral health initiative to raise awareness on the long-term impact of tooth loss while ensuring that underprivileged Malaysian communities have access to world-class dental products and services for a better quality of life. We look forward to working closely with our local counterparts to bring the Programme to life while supporting MOH in its ambitions under the National Oral Health Plan 2021-2030."

About Straumann Group

The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials and digital solutions for use in tooth correction, replacement and restoration or to prevent tooth loss.

Headquartered in Basel, Switzerland, the Group currently employs more than 9000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners. For more information, please visit our website at: https://www.straumann.com

Media Contacts:
Lok Ru Jun
Narro Communications
E: rujun@narrocomms.com
T: +6012 339 0613

Cheong Sue Fyenn
Narro Communications
E: suefyenn@narrocomms.com
T: +6016 910 7625


Topic: Press release summary
Source: Straumann Group

Sectors: Healthcare & Pharm, Local Biz
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Tenstorrent Unveils TT-QuietBox(TM) 2, the First RISC-V AI Workstation With a Fully Open-Source Stack to Deliver Teraflop-Class Inference  
Mar 12, 2026 00:00 HKT/SGT
Yuexiu REIT Maintains Operational Resilience, Revenue Exceeds RMB1.8 Billion in 2025  
Mar 11, 2026 19:16 HKT/SGT
Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis  
Wednesday, March 11, 2026 7:15:00 PM
MarketingPulse and eTailingPulse open next Thursday  
Mar 11, 2026 16:54 HKT/SGT
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting   
Wednesday, March 11, 2026 11:07:00 AM
JOYY Reports 4Q and FY2025 Financial Results: Q4 Revenue Returns to YoY Growth, BIGO Ads Up 61.5% YoY  
Mar 11, 2026 09:40 HKT/SGT
Kincora Consolidates, Commences Geophysics and Forms Partnership at Cowal East  
Mar 10, 2026 17:59 HKT/SGT
Fosun Navigates Cyclical Volatility and Clears Risks as Management Reaffirms RMB10 Bn Profit Target for Next 3 to 5 Yrs  
Mar 10, 2026 15:45 HKT/SGT
Impro Precision 2025 Profit Attributable to Shareholders Reaches Record High of HK$726.2 Million, Up 12.7% Year-on-Year, Forecast 2026 Sales Growth Rate to Accelerate to Mid-Double Digits  
Mar 10, 2026 14:19 HKT/SGT
Natural Beauty's 2025 Annual Results Show Steady & Robust Growth  
Mar 10, 2026 13:35 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: